MOSCOW, May 5. /TASS/: Russia’s Health Ministry has registered a coronavirus drug called Mirobivir developed by the Pharmasyntez company, according to the state register of medicines.
Mirobivir, based on the combination of nirmatrelvir and ritonavir, was registered on May 4 and will be available in tablet form with 150 + 100 mg strength.
